Enhanced long-term expression from helper virus-free HSV-1 vectors packaged in the presence of deletions in genes that modulate the function of VP16, U L 46 and U L 47.
Herpes simplex virus (HSV-1) gene expression is hypothesized to shut off recombinant gene expression from HSV-1 vectors, but in a helper virus-free HSV-1 vector system, a number of promoters support only short-term expression. Thus paradoxically, recombinant gene expression remains short-term in the absence of almost all (approximately 99%) of the HSV-1 genome. To resolve this paradox, we hypothesize that specific HSV-1 proteins that affect the virion can shut off recombinant gene expression. In an earlier study, we examined the effects on recombinant gene expression of five different proteins that affect the HSV-1 virion. We found that vectors packaged in the presence of mutated vhs or U S 11 exhibited minimal changes in gene expression, vectors packaged in the presence of a mutated U S 3 supported improved gene transfer (numbers of cells at 4 days), and vectors packaged in the presence of mutated U L 13 or VP16 supported improved long-term expression. The capability of the VP16 transcriptional complex to reduce gene expression deserves additional study because VP16 is a powerful enhancer that interacts with a number of cellular and viral proteins. In particular, U L 46 and U L 47 are known to modulate the effects of VP16 on immediate early promoters. In this study, we examined expression from a HSV-1 vector that contains a neuronal-specific promoter and was packaged in the presence of deletions in U L 46, or U L 47, or both U L 46 and U L 47. In the rat striatum, each of these vector stocks supported both improved gene transfer (numbers of cells at 4 days) and improved long-term expression (2 months). Vectors packaged in the presence of a deletion in both U L 46 and U L 47 supported larger improvements in gene expression compared to vectors packaged in the presence of deletions in either gene alone. The implications of these results for strategies to improve long-term expression are discussed.
Liu
Meng
M
Department of Neurology, Research Building 3, West Roxbury, VA Hospital/Harvard Medical School, 1400 VFW Parkway, W. Roxbury, MA 02132, USA.
Tang
Ju
J
Wang
Xiaodan
X
Yang
Tianzhong
T
Geller
Alfred I
AI
D000818:Animals; D000956:Antigens, Viral / Q000235:genetics*; D003342:Corpus Striatum / Q000821:virology; D003360:Cosmids / Q000235:genetics; D006224:Cricetinae; D017353:Gene Deletion; D015870:Gene Expression; D018014:Gene Transfer Techniques; D005822:Genetic Vectors; D006378:Helper Viruses / Q000502:physiology*; D017405:Herpes Simplex Virus Protein Vmw65 / Q000235:genetics; D018259:Herpesvirus 1, Human / Q000502:physiology*; D008845:Microinjections; D011401:Promoter Regions, Genetic; D051381:Rats; D013997:Time Factors; D014760:Viral Fusion Proteins / Q000235:genetics*; D014764:Viral Proteins / Q000235:genetics*
D000956:Antigens, Viral; D017405:Herpes Simplex Virus Protein Vmw65; C414831:UL46 protein, Human herpesvirus 1; C085822:VP13-14 protein, herpes simplex virus type 1; D014760:Viral Fusion Proteins; D014764:Viral Proteins